Internal Medicine, Pulmonary Disease · San Juan, PR
NPI
1497745129
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
Edif Clinica Las Americas Ofic 205, 400 Roosevelt Ave
San Juan, PR, 00918
Phone (787) 765-1919
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
968 services
Medicare patients, 2024
205
Average age 77
Drug cost, 2024
$1.5M
3,383 prescriptions
Company payments, 2025
$2,118
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandra E Rosario Lebron was code 99213 (office e&m - established), 356 times for 173 patients. In total Sandra E Rosario Lebron billed 968 services in 18 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 356 | 173 | $63.46 | $23K |
| 94375 Pulmonary Function Testing | Office | 205 | 167 | $27.51 | $5,640 |
| 94727 Pulmonary Function Testing | Office | 153 | 149 | $33.02 | $5,051 |
| 94729 Pulmonary Function Testing | Office | 153 | 149 | $41.11 | $6,290 |
| 99203 Office E&M - New | Office | 39 | 39 | $74.01 | $2,887 |
| G0008 Administration of influenza virus vaccine | Office | 14 | 14 | $15.58 | $218 |
| 90658 Vaccine Product | Office | 14 | 14 | $21.41 | $300 |
| 94618 Pulmonary Function Testing | Office | 13 | 11 | $24.55 | $319 |
By year: 2022 $39K for 755 services; 2023 $44K for 859 services; 2024 $44K for 968 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sandra E Rosario Lebron prescribed most often to Medicare patients was Fluticasone Propionate, with 487 prescriptions and refills. In total Sandra E Rosario Lebron wrote 3,383 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 487 | 566 | 225 | $8,983 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 367 | 372 | 84 | $246K |
| Montelukast Sodium Generic | 248 | 350 | 73 | $2,812 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 242 | 260 | 95 | $34K |
| Breo Ellipta Fluticasone/Vilanterol | 213 | 214 | 48 | $88K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 151 | 195 | 59 | $6,198 |
| Azithromycin Generic | 144 | 144 | 104 | $1,244 |
| Azelastine Hcl Generic | 139 | 358 | 79 | $3,174 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 123 | 125 | 25 | $61K |
| Prednisone Generic | 121 | 123 | 41 | $602 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 105 | 130 | 37 | $28K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 93 | 95 | 24 | $61K |
| Symbicort Budesonide/Formoterol Fumarate | 76 | 81 | 29 | $18K |
| Spiriva Respimat Tiotropium Bromide | 70 | 70 | 16 | $37K |
| Methylprednisolone Generic | 69 | 69 | 54 | $682 |
Brand drugs: - claims; generic drugs: 1,870 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandra E Rosario Lebron $2,118 ($2,118 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $583.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $583 |
| Viatris Specialty LLC | 10 | $254 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $245 |
| GlaxoSmithKline, LLC. GSK | 6 | $147 |
| Merck Sharp & Dohme LLC MRK | 6 | $140 |
| Genzyme Corporation SNY | 5 | $130 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 5 | $124 |
| United Therapeutics Corporation UTHR | 4 | $101 |
| Pbg Puerto Rico LLC | 4 | $92.36 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $85.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.